MIDATECH
LIVE

Serial Number

79135148

Owner

Midatech Limited

Attorney

Manuel R. Valcarcel

Filing Date

Apr 2, 2013

Add to watchlist:

No watchlists yet
View on USPTO

MIDATECH Trademark

Serial Number: 79135148 • Registration: 4680241

MIDATECH is a trademark filed by Midatech Limited on April 2, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Midatech Limited (9 trademarks)

Oddfellows House,

Entity Type: 99

Trademark Details

Filing Date

April 2, 2013

Registration Date

February 3, 2015

Published for Opposition

November 18, 2014

Cancellation Date

April 2, 2023

Goods & Services

[ Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices ]

[ Computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions; electronic devices, namely, computers, laboratory analyzers in the nature of residual gas analyzers, liquid analyzers, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence or quantity of target chemicals, biologics, contaminants and nano-particles, untrasound probes for testing nano-particles for non-medical purposes, scientific diagnostic apparatus in the nature of diagnostic apparatus for testing food, diagnostic apparatus for the detection of pathogens for laboratory or research use, spectroscopic devices in the nature of laboratory spectroscopes, microfluidic devices in the nature of electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, laboratory equipment in the nature of digital microfluidic instruments for nucleic acid sample preparation, laboratory equipment in the nature of digital microfluidic instruments for genomic analysis, equipment for microfluidic analysis, research laboaratory analyzers for measuring, testing and analyzing fluids, laboratory microarray devices for the sampling, collection, analysis and testing of nano-particles ]

[ Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles ]

[ Active chemical ingredients for use in the manufacture of pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; Active chemical ingredients for use in the manufacture of cosmetics, namely, nanoparticles for use as carriers for cosmetic preparations; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics, namely, active chemical ingredients in the nature of nanoparticles for use in the manufacture of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders ]

[ Medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, medical sample preparation devices for medical diagnostic uses, spectroscopic devices in the nature of microscopes for surgical operations, endoscopic equipment, otoscopes, microfluidic devices in the nature of medical fluid injectors, medical devices for obtaining body fluid samples containing nano-particles and medical diagnostic instuments for analysis of body fluids, microarray devices in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes; probes for medical purposes ]

[ Scientific research services in the field of nano-particle technology; ] pharmaceutical development and drug development and discovery services; testing, efficiency, quality evaluation and technical advisory services in the field of design, development and scientific research of [ nano-particles, ] pharmaceuticals [ and nano-medicine; nano-particle testing, quality evaluation and scientific research laboratory services ]

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 30, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 30, 2023 DETH
PARTIAL INVALIDATION PROCESSED BY THE IB
Jan 3, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 2, 2022 INPS
INVALIDATION PROCESSED
Dec 1, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 5, 2022 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 5, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 5, 2022 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 16, 2022 APRE
TEAS SECTION 71 RECEIVED
Jul 26, 2021 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2020 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 3, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 10, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 20, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 3, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 3, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 3, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2014 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Nov 14, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 29, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 29, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 16, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 14, 2014 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2014 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2014 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2014 CRFA
ASSIGNED TO LIE
Mar 20, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2014 TROA
REFUSAL PROCESSED BY IB
Sep 30, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 10, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 10, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2013 RFCR
APPLICATION FILING RECEIPT MAILED
Sep 10, 2013 MAFR
NON-FINAL ACTION WRITTEN
Sep 9, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 6, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 5, 2013 REPR